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Abstract
This study aims to investigate the clinimetric properties of ACTIVLIM, a measure of activity limitations, when it is used in daily practice in
a large nationwide representative cohort of patients with neuromuscular diseases. A cohort of 2986 patients was assessed at least once over 2 years
in 6 national neuromuscular diseases reference centers. Successive Rasch analyses were conducted in order to investigate the scale validity,
reliability, consistency across demographic and clinical sub-groups and its sensitivity to change. ACTIVLIM confirmed excellent fit to a
unidimensional scale, with stable but 3-times more accurate item calibrations compared to the original publication. It showed a good reliability
(R = 0.95), an appropriate targeting for 87% of the sample and an excellent invariance across age, gender, language and time. Despite some
variations in the item difficulty hierarchy across diagnoses, ACTIVLIM exhibited a good capability to quantify small but significant changes in
activity for various diagnostic groups. Overall, ACTIVLIM demonstrated very good clinimetric properties, allowing accurate quantitative
measurement of activity limitations in both children and adults with a variety of neuromuscular diseases.
© 2015 Elsevier B.V. All rights reserved.
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1. Introduction
Questionnaire-based instruments have demonstrated their
usefulness in various clinical assessments. They are more
frequently incorporated in clinical practice in many fields and
in health care policy planning [1–3]. For example, ACTIVLIM
is being used by reference centers in Belgium to observe the
course of neuromuscular disease (NMD) in adult and pediatric
patients, through the Belgian NeuroMuscular Disease Registry
(BNMDR) [4]. ACTIVLIM is a measure of activity limitations
in everyday life in children and adults with NMD [5,6]. It
consists of a questionnaire including 22 items that describe
activities of daily living, among which four are specific for
children and another four for adult patients. The remaining 14
items are common for all NMD patients. For each item,
patients are asked to report their perceived difficulty in performing
each activity without human or technical assistance on a
three-category rating scale: “impossible”/“difficult”/“easy”, scored
as 0, 1 or 2, respectively. Activities unfamiliar to the
patient that were not attempted in the last 3 months are scored
as missing. The items are presented in 10 different random
orders in order to avoid systematic biases related to a repeated
item presentation sequence. The development and validation
of the ACTIVLIM questionnaire was based on the Rasch
model [7] which has become a state-of-the-art practice
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in scales development and evaluation in health measurement
[8].
Questionnaires such as ACTIVLIM are more and more used
to follow-up chronic conditions such as stroke, chronic
obstructive pulmonary diseases or neuromuscular diseases.
However, most of available questionnaires lack assessment of
their sensitivity to change, also known as responsiveness [9,10].
Moreover, when used across a varied clinical case mix, it must
be checked that questionnaire items are free from bias towards
one or more diagnostic group(s), different stages of diseases,
different age groups or, for instance, be systematically easier
for females than for males. Essentially, in order to compare
measures across diagnoses, stage of disease or across gender, it
must be checked that the questionnaire items retain a consistent
difficulty whatever individual patient is being assessed and
between time of assessment [11,12]. The routine use of the
ACTIVLIM through the BNMDR provides the opportunity to
more deeply investigate the psychometric properties of this
questionnaire as described in its original validation [5].
The present study aims to investigate the psychometric
properties of the ACTIVLIM when used in clinical daily
practice in a large cohort of patients with neuromuscular
diseases with a representative case mix. More specifically, the
aim of this study was to validate the use of ACTIVLIM as a
patient-reported questionnaire in daily clinical practice in the
BNMDR by (1) investigating the robustness of ACTIVLIM
calibration by comparing the item hierarchy in the BNMDR
with the original calibration, (2) testing the fit of ACTIVLIM
data to a unidimensional construct allowing the quantitative
measurement of activity limitations in patients with NMD, (3)
investigating the invariance of ACTIVLIM between
demographic and clinical sub-groups in the BNMDR, (4)
examining the reliability in this sample and (5) measuring the
patients’ change in activity over one year.
2. Materials and methods
2.1. Ethics statement and data collection
The BNMDR project, which includes the ACTIVLIM data
collection and analysis, has been approved by the medical
ethics committees of the participating neuromuscular centers.
Each patient signed a consent form to participate in the
BNMDR. ACTIVLIM data were collected over 2 years (2011–
2012) in 6 neuromuscular reference centers. The ACTIVLIM
questionnaire is available with items presented in 10 different
random orders to avoid any systematic effect due to item
sequences. A set of 10 questionnaires with different orders was
distributed before issuing another set. Patients received the
questionnaire either directly from clinicians during visits at
their neuromuscular reference centers or by mail. In the present
study, 4146 valid records were included. This sample comprises
56% male, 92% adult patients, and 85% of patients were of
Flemish origin (Table 1).
2.2. Data analysis
The psychometric qualities of the ACTIVLIM were
investigated with RUMM2030, a comprehensive Rasch analysis
software package [13–17]. The Rasch model formulates the
requirements for objective measurement of latent variables
such as patient-reported limitations of activity. It requires that
the response of a patient to an item solely depends on the
patient activity and the item difficulty (also including the
relative threshold difficulty of selecting between two consecutive
responses). The ACTIVLIM data were analyzed with the
rating scale Rasch model [13] that assumes equidistance between
consecutive thresholds across all items. This model was chosen
in order to comply with the original item design [5] and to
simplify the clinical interpretation of patient response patterns
[18,19]. The model estimates the location of the patients (i.e.
their level of activity) and of the items and thresholds (i.e.
their relative difficulty) on a common underlying unidimensional
linear scale of activity limitations [20]. Based on the estimated
locations, the expected answer of each patient to each item can
be computed and compared with the responses actually reported
by the patients in order to determine how well the observed
data fit the model requirements of order, invariance and
unidimensionality [7,17,20–24]. The level of significance was
set to 0.05 and the Bonferroni adjustment was applied for
multiple analyses.
The internal validity of ACTIVLIM was examined by testing
the fit of the items to the Rasch model by dividing the BNMDR
sample in 6 class interval of increasing ability. The deviation
from the model expectation was assessed through standardized
residuals (expected range between −2.5 and +2.5) [12], and
chi-square statistics [17]. Since the statistical significance of
any misfit depends on sample characteristics such as sample
size and targeting [25] with larger samples systematically
providing higher significance, a sample size of 400 (similar to
the sample size of the original calibration [5]), was used for the
assessment of chi-square statistical significance [26,27]).
The measurement range, item difficulty targeting to patient
abilities and measurement error were assessed through a
reliability analysis. The measurement range was determined as
the region between the easiest and the most difficult item
threshold along the underlying continuum of activity
limitations. The floor and ceiling effects in the dataset were
computed as the proportion of patients located, respectively,
below and above the measurement range. The person separation
index (PSI, range: 0 to 1) was computed as the ratio between the
spread of the patient locations (as expressed by their standard
deviations corrected for measurement error) and the
measurement error, indicating the extent to which distinct
levels of ability can be distinguished in the sample [12,23,28].
The local dependence, i.e. the redundancy that links responses
to different items once the main underlying trait is factored out
and that might artificially inflate reliability [12,29] was
investigated by examining the residual correlation matrix. Items
presenting residual correlations above 0.3 were considered as a
potential source of local dependence [30].
The invariance, or consistency, of the item difficulties
between demographic and clinical patient subgroups was
investigated through differential item functioning (DIF)
analysis, in order to investigate whether different subgroups
within the sample (e.g. males vs. females) respond in a different
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way to individual items, despite equal levels of activity. The
DIF analysis was conducted by splitting the sample of patients
according to the following demographic and clinical sub-
groups: gender (male vs. female), age (different groups of age
classes), administrative language (Dutch vs. French) of the
center where the patient was evaluated, type of disease
(proximal vs. distal NMDs), symptom duration (less vs. more
than the median duration of 8 years), stage of disease (only
wheelchair dependent vs. symptomatic ambulatory), and
diagnosis (across the 9 most prevalent diagnoses). Age classes
were obtained using two approaches: (1) division of the sample
in groups of 10 years with subjects of less than 16 years old
gathered in the same age group and (2) dichotomous split of the
adult sample on the median age of 52 years. Two methods were
used for the DIF tests. For dichotomous factors (e.g. gender) the
consistency of item hierarchy was tested by determining the
item difficulty for each subgroup (e.g. one analysis for males
only and one for females only), then comparing both sets of
item difficulty on a XY plot [24] using standard errors
normalized for large samples [26]. For polytomous factors (e.g.
9 most prevalent diagnoses), the invariance was tested by a
two-way ANOVA on the residuals in order to determine if the
residuals vary between subgroups (e.g. diagnoses) and/or
between levels of activity [31]. Similarly, the ACTIVLIM item
difficulty hierarchy in the present sample was compared to the
original calibration [5] and between 2011 and 2012 in the
BNMDR dataset.
The change in activity limitations over time was measured as
the difference in patients’ activity between 2011 and 2012 for
those 1128 patients who were evaluated in both years. For
patients assessed twice or more in each year, only the first
assessment was taken into account for this analysis. Individual
patients’ change was computed according to the following
t-score:
t
m m
SE SE
=
−
+
2 1
2
2
1
2( ) ( )
to characterize the distribution of change across time, where
m1 = patient measure in 2011; m2 = patient measure in 2012;
SE1 = patient measure standard error in 2011 and SE2 = patient
measure standard error in 2012. Then, the patient’s change
was qualified as “significant improvement” for t > 1.96,
“improvement” for 0 < t ≤ 1.96, “stable” for t = 0,
“deterioration” for −1.96 ≤ t < 0 or as “significant
deterioration” for t < −1.96.
Table 1
BNMDR dataset overview.
Parameter and level 2011 (n = 1820) 2012 (n = 2326) 2011 & 2012 (n = 4146)
Gender
Male, n (%) 1027 (56%) 1276 (55%) 2303 (56%)
Female, n (%) 793 (44%) 1050 (45%) 1843 (44%)
Age
Children, age of 6 to 15 y, mean of 11.01 ± 2.95 y, n (%) 159 (9%) 166 (7%) 325 (8%)
Adults, age of 16 to 92 y, mean of 50.57 ± 17.79 y, n (%) 1661 (91%) 2160 (93%) 3821 (92%)
Language
French, n (%) 375 (21%) 265 (11%) 640 (15%)
Dutch, n (%) 1445 (79%) 2061 (89%) 3506 (85%)
Item Orders
1 to 10, range (mean) 117–356 (182) 224–250 (233) 344–592 (415)
Symptoms duration
Range, y (n) 2–73 (440) 1–79 (528) 1–79 (968)
<8 y 207 273 480
≥8 y 233 255 488
Stage of disease, n
Diagnosis 47 109 156
Symptomatic Ambulatory 1256 1577 2833
Wheelchair dependent 397 519 916
Prolonged survival 15 43 58
Missing 105 78 183
NIHDI classification, n for adults/children
Hereditary Motor and Sensory Neuropathy (HMSN) 209/26 286/38 495/64
Myotonic Dystrophy type 1 (MD1) 238/14 274/15 512/29
Amyotrophic Lateral Sclerosis (ALS) 195/0 266/0 461/0
Hereditary Spastic Paraplegia (HSP) 93/3 140/5 233/8
Limb Girdle Muscular Dystrophy (LGMD) 88/4 109/6 197/10
Spinocerebellar Ataxia (SCA) 87/0 113/0 200/0
Duchenne Muscular Dystrophy (DMD) 41/54 52/41 93/95
Facioscapulohumeral Muscular Dystrophy (FSHD) 56/1 78/4 134/5
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 50/0 71/0 121/0
Spinal Muscular Atrophy (SMA) 30/10 45/15 75/25
Other 574/47 726/42 1300/89
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3. Results
3.1. Psychometric properties of the ACTIVLIM in the
BNMDR
Among the 22 ACTIVLIM items, bathing and showering
were the less scored activities in the BNMDR adult sample
with, respectively, 5% and 9% of responses missing. The
distribution of missing responses did not vary among the 10
item orders. The present analyses demonstrated acceptable
overall fit statistics for both items (mean ± SD: −1.02 ± 2.82)
and persons (mean ± SD: −0.42 ± 1.11), where fit statistics are
standardized to a mean of 0 and a SD of 1. There was a
non-significant item-trait interaction (chi-square = 127.8;
df = 110; p = 0.12) indicating that the relative difficulties of the
items were consistently ranked by the patients whatever their
ability.
Regarding individual item fit (Table 2), 16 out of 22 items
exhibited negative standardized residuals, indicating a
predictable response with little randomness that is typically not
considered as a threat to unidimensionality. Seven of the 16
items exhibited a fit residual lower than −2.5; however, this over
fit had no threat to the model. Five of the 16 items demonstrated
a low chi-square probability (p < 0.05), that however remained
above the Bonferroni adjusted threshold of 0.002 [32]. In
addition, only two items, namely (1) “Running” for children
only and (2) “Standing for a long time” for adults only,
exhibited a positive standardized residual over 2.5 with non-
significant chi-square probabilities, i.e. a response that is more
systematic than expected, but not significantly. This indicates
that there was no significant misfit of the items to the Rasch
model.
The average patient standardized residual (−0.42 ± 1.11) is
relatively close to the ideal expected value of 0 ± 1 in case of
perfect fit. A closer examination of individual person fit
indicated that the standardized residual was below −2.5 in 62
records and above 2.5 in 65 records. This indicates that 97% of
the total records (4019 out of 4146) fitted the Rasch model
requirements.
The total range of measurement in this dataset varied from
−5.3 to over +5.4 logits. The distribution of patients’ abilities
(Fig. 1) was well targeted to the distribution of item thresholds.
Only 318 records (7.7%) were extremely low (i.e. patients had
rated all items as “impossible”) and only 221 records (5.3%)
were extremely high (i.e. patients had rated all items as “easy”).
This indicates that the ACTIVLIM demonstrated low floor and
ceiling effects as the range of item difficulty was well targeted
for 87% of the patients in the BNMDR dataset.
A PSI of 0.95 indicates a very good reliability in the
BNMDR dataset showing that 6 strata of significantly different
levels of ability can be distinguished in the functional range of
measurement of ACTIVLIM [33,34]. The average standard
error on the item difficulties was 0.05 logits.
Examination of the residual correlation matrix highlighted
that most of the correlations were below 0.3, except for 3 pairs
of items that presented weak to moderate residual correlations:
items “Taking a bath” and “Stepping out from a bath tub” with
r = 0.41; items “Walking downstairs” and “Walking upstairs”
with r = 0.46 and items “Washing one’s upper body” and
“Wiping one’s upper body” with r = 0.61.
3.2. Comparison of BNMDR and original calibration
The stability of the item difficulty hierarchy between the
BNMDR and the original calibration is illustrated in Fig. 2.
Although there were slight but non-significant changes in some
items’ location, all items lie within the 95% confidence interval
of invariant calibration. The item “Hopping on one foot” has
Table 2
Calibration of ACTIVLIM for the BNMDR dataset.
Item and statement Group* Difficulty (logit) SE (logit) Fit Residual Chi Square p-value
a. Hopping on one foot C 3.19 0.09 −0.35 0.74 0.981
c. Running C 3.00 0.09 4.78 1.80 0.877
b. Carrying a heavy load A 2.91 0.04 −1.28 4.95 0.423
d. Walking more than 1 km A 2.14 0.04 −0.30 8.12 0.150
f. Standing for a long time A 1.44 0.04 4.30 2.18 0.824
g. Stepping out of a bath tub B 1.35 0.04 −4.60 5.28 0.383
e. Walking upstairs B 0.96 0.03 −3.53 12.40 0.030
i. Taking a bath B 0.94 0.04 −1.30 18.86 0.002
h. Walking downstairs B 0.59 0.03 −5.33 3.17 0.673
j. Putting on a backpack C 0.41 0.08 0.74 0.60 0.988
l. Walking outdoors on level ground B −0.08 0.03 −0.28 1.83 0.873
k. Dressing one’s lower body B −0.09 0.03 −4.72 6.57 0.255
n. Taking a shower B −0.27 0.04 −3.94 11.62 0.040
m. Getting into a car A −0.63 0.04 −3.29 14.96 0.011
o. Wiping one’s upper body B −1.40 0.04 −1.48 4.06 0.541
s. Washing one’s upper body B −1.49 0.04 −1.48 4.97 0.419
q. Hanging up a jacket on a hatstand B −1.56 0.04 −2.34 12.69 0.026
r. Sitting on the toilet B −1.60 0.04 −3.24 4.67 0.457
p. Putting on a T-shirt B −1.75 0.04 −0.74 1.83 0.872
u. Closing a door C −2.35 0.11 1.09 2.65 0.754
t. Opening a door B −2.46 0.04 2.34 1.87 0.867
v. Washing one’s face B −3.25 0.05 2.43 2.05 0.843
* A = adult only activity, C = child only activity and B = activity common to both children and adults.
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remained the most difficult item and item “Washing one’s face”
the easiest one.
In addition, there was no significant difference between 2011
and 2012 regarding the item difficulty hierarchy (Fig. 2).
Therefore, data from both years were pooled together to
evaluate the validity of ACTIVLIM in the BNMDR dataset.
3.3. Differential item functioning
The results of the DIF tests for dichotomous factors are
presented in Fig. 3, where the item relative difficulties are
compared between various complementary sub-groups of
patients (e.g. males vs. females). Overall, the item difficulty
hierarchy in the BNMDR dataset was not significantly different
between males and females, between younger and older adults,
between Dutch and French speaking patients, between patients
with proximal or distal NMDs, between patients with recent or
long-established symptoms and between ambulatory and
wheelchair-dependent patients. However, minor exceptions
were observed. For example, items e and h, namely “Walking
upstairs” and “Walking downstairs”, were perceived as more
Fig. 1. Distribution of patient activity (top) in 2011 (blue) and 2012 (red) and of ACTIVLIM item thresholds (bottom). Positive locations indicate more able patients
and more difficult items. An activity of zero is conventionally set at the average item difficulty. Each item is represented by two thresholds (one at the threshold
between “impossible” and “difficult” responses and one at the threshold between “difficult” and “easy” responses), separated by 2.89 logits.
Fig. 2. Comparison of BNMDR and original calibration of ACTIVLIM (left panel) and item hierarchy in BNMDR 2011 and 2012 (right panel). More difficult items
are plotted in the top/right part of each plot. All items (dots) lie within the 95% confidence interval (curved lines) of the ideal invariance (straight line), showing the
same perceived item difficulty between conditions.
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difficult by patients with symptom durations over 8 years than
by patients with more recent symptoms; item l, namely
“Walking outdoors on level ground”, was perceived as more
difficult by wheelchair-bound than by ambulatory patients and
item f, namely “Standing for a long time”, was perceived as
more difficult by patients with distal rather than proximal
NMDs.
The results for DIF tests involving polytomous sub-groups
are presented in Fig. 4. Whereas, the overall item difficulty
hierarchy was stable, and minor exceptions to the ideal
invariance were observed across age sub-groups. For instance,
some locomotion items, namely “Walking upstairs” and
“Walking outdoors on level ground” were perceived as easier
while some dressing and grooming activities, namely
“Washing-” and “Wiping-one’s upper body” and “Putting on a
T-shirt” were perceived as more difficult by children than by
other age groups. In addition, the slight divergence of item
difficulties across the 9 most prevalent diagnoses suggests the
presence of pathology-specific patterns of item difficulty. Two
types of patterns are observed: (1) large deviations from the
average item difficulty hierarchy are observed for diagnoses
weakly represented in the sample; for instance, a large deviation
in the difficulty of items “Hopping on one foot” and “Hanging
up a jacket on a hatstand” is perceived by patients with Chronic
Inflammatory Demyelinating Polyradiculoneuropathy (CIDP);
(2) small deviations from the average item difficulty hierarchy
are observed for diagnoses with larger sample size; for instance,
a small deviation in the difficulty of medium difficult and easy
items is perceived by patients with Amyotrophic Lateral
Sclerosis (ALS).
3.4. Change in patients’ activity level over time
The distribution of t-scores, representing individuals’ change,
is presented in Fig. 5. In the whole sample of 1128 patients,
the level of activity has remained stable for 14% of the patients
over one year. Activity significantly deteriorated in 14% of the
patients while non-significant deterioration was observed in
38%. Non-significant improvement of activity was observed in
Fig. 3. Differential Item Functioning plots for 6 dichotomous sub-groups. In each plot, items (dots) lying within the 95% confidence interval (solid lines) of the ideal
invariance have the same difficulty for both sub-groups. Outliers are identified by their labels. Proximal NMDs are Duchenne Muscular Dystrophy, Becker Muscular
Dystrophy, Limb Girdle Muscular Dystrophy, Emery-Dreifuss Muscular Dystrophy, Polymyositis, Dermatomyositis, Adult Spinal Muscular Atrophy, X-linked
Bulbo-Spinal Muscular Atrophy or Kennedy’s disease; Distal NMDs are Distal Myopathy, Myotonic Dystrophy type 1, Distal Spinal Muscular Atrophy, Hereditary
Spastic Paraplegia, Hereditary Motor and Sensory Neuropathy, Neuropathy associated with Paraproteinemia, Neuropathy associated with Plasma Cell Dyscrasia,
Amyloidosis, Neuropathy in Systemic Disease, Other Neuropathies.
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28% of the patients while 6% of them significantly improved.
A comparable pattern of change was observed for all diagnostic
sub-groups, except for ALS where larger deteriorations were
observed over one year (t-score = −1.68 ± 2.17; p < 0.001) and
for CIDP showing a more stable or improving condition
(t-score = +0.49 ± 1.65; p > 0.1).
4. Discussion
This study aimed at investigating the metric properties of the
ACTIVLIM scale as it is used in daily practice in the BNMDR.
Analyses showed a good overall and individual item and person
fit to a unidimensional scale, a high reliability index and a good
targeting between the scale and the population of interest. The
item hierarchy was also stable over time and invariant across
selected demographic and clinical factors. Analyses of
sensitivity to change over one year revealed that the
ACTIVLIM questionnaire has a good responsiveness, and is
suitable as a tool for the follow-up of activity limitations in
patients with neuromuscular diseases taking into account the
dynamic of various NMD diseases. These results confirmed the
validity of ACTIVLIM in adult and pediatric patients with
NMD since the patient fit statistics, namely the standardized
residuals, are acceptable for all diagnostic and age groups. This
indicates that ACTIVLIM measures the limitation of activities
in a consistent way across the diagnoses represented in the
sample.
4.1. Consistency of item calibration over time
Although the metric of ACTIVLIM definition is consistent
between the original calibration paper [5] and our study, minor
hierarchical re-orderings appeared for some items. While the
original item calibration was estimated from the response of
369 patients, the present calibration is based on a sample of
4146 records. Consequently, the average standard error on the
Fig. 4. Differential Item Functioning plots for age and diagnosis sub-groups. In each plot, item difficulties are plotted for each sub-group (symbols and lines) on top
of the average item difficulty for the whole sample (thick gray line). Items are listed from top to bottom in decreasing difficulty order for the whole sample. Where
symbols lie close to the average item difficulty, items have an invariant difficulty among sub-groups. Items with difficulties widespread between sub-groups display
some DIF.
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item difficulty has dropped from 0.17 to 0.05 logits, showing
that the BNMDR sample allowed an estimation of the item
difficulty, i.e. the metric definition of the ACTIVLIM activity
limitation scale, with an accuracy that is over 3-fold the
accuracy of the original study. Although the minor re-ordering
of items observed between the original [5] and the present
studies might be due to the increased accuracy in the current
study, it did not lead to a significant change in the item difficulty
hierarchy. It is notable that the item hierarchy remained stable
over time and despite differences in data collection contexts and
sample size. Indeed, while in the original study, data were
collected by a single rater, the present study used data collected
through daily recordings in clinical practice with multiple
raters. Altogether, the invariance of the item difficulty hierarchy
demonstrates the robustness of the ACTIVLIM scale in the
measurement of activity limitations in NMD patients.
4.2. Metric properties of ACTIVLIM
The range of non-extreme abilities measured in the BNMDR
dataset varies from −5.3 to over +5.4 logits, while it ranges from
approximately −5 to +5 logits in the original study [5],
indicating that the BNMDR patient sample is slightly more
spread than the original sample. Moreover, the Person
Separation Index in the BNMDR (PSI = 0.95) and in the
original study (0.96) were similar. This observation supports the
reliability of the ACTIVLIM in the BNMDR dataset. Despite
difference in data collection between this study and the original
study [5], only a slight decrease in PSI (0.95 vs. 0.96) was
observed. A reliability of 0.95 allows over 6 distinct strata of
significantly different abilities to be distinguished [33]. This
indicates that ACTIVLIM can discern subtle but statistically
significant differences in clinical practice. However, the PSI
might be inflated by response dependence [12]. Although local
dependency is not reported in the original study, it has been
shown that three pairs of items presented moderate residual
correlations (0.41 ≤ R ≤ 0.61), which might have artificially
impacted the PSI in the BNMDR. Indeed, correlated residuals
are typically observed for items with comparable meanings
(e.g. “Walking upstairs” and “Walking downstairs”) and such
redundant items may also artificially inflate reliability indices
since they challenge the same aspect of the patient’s ability.
Alternatives to this potential issue consist either in deleting the
redundant item(s) [35] or in analyzing the existing responses by
merging the redundant items into one single item [17].
4.3. Invariance of the ACTIVLIM item difficulty hierarchy
across demographic and clinical subgroups
The robustness of the ACTIVLIM calibration was
established across various demographic and clinical sub-
groups. However, the largest variations in item difficulty
hierarchy appeared between diagnoses. The interpretation of
these differences is complicated by the case mix since large
differences in diagnoses with small sample size may be less
significant than small differences in diagnoses with large
sample size. While the application of the common item
hierarchy is supported by the good patient fit across all
diagnostic groups, the observed diagnosis-specific pattern fits
with the clinical picture. Activities that involve distal muscles,
e.g. items “Closing a door”, “Standing for a long time” and
“Running” were rated as more difficult for distal than for
proximal NMDs; they, indeed, require ankle stabilization or
hand/arm activity. On the other hand, the item “Walking
upstairs” was more difficult for proximal NMDs, requiring
activity of proximal muscles such as psoas and quadriceps.
Fig. 5. Distribution of patients’ change of activity from 2011 to 2012. Positive
t-scores indicate an increase of activity for a patient over one year and negative
values indicate a decrease of activity over one year.
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Items “Walking upstairs” and “Walking downstairs” were more
difficult for patients with symptoms lasting more than 8 years.
This might be age-related since patients with long lasting
symptoms will be adults or old adults rather than children and
thus might be less inclined to climb stairs. Activities relative to
grooming and dressing the upper body appeared easier for
Hereditary Spastic Paraplegia (HSP), a disease that does not
impact upper limbs, and for Amyotrophic Lateral Sclerosis
(ALS) which mainly affects lower limbs. Similarly, activities
that require the use of upper limbs presented a higher challenge
for facioscapulohumeral muscular dystrophy (FSHD) patients
whereas items requiring essentially the lower limb, e.g.
“Hopping on one foot”, “Running”, “Walking more than 1 km”
and “Standing for a long time”, were relatively easier for these
patients since FSHD mainly affects the neck and shoulders. The
analysis of DIF across age revealed that children reported less
difficulty in stairs climbing. This might be explained by their
smaller sensitivity to fatigue as compared to adults. The easier
outdoor locomotion might be explained by their larger interest
in outdoor activities in general (e.g. playing). The observed
differences in item difficulty hierarchy between diagnoses may
raise the debate on generic versus disease-specific scales.
Despite minor variations in ACTIVLIM item difficulty
hierarchy across diagnoses, individual diagnoses demonstrated
an overall good fit, with standardized residuals (mean ± SD)
ranging from −0.67 ± 1.03 to 0.00 ± 1.28, when using a
common item hierarchy for a variety of neuromuscular
diseases. In addition, despite a total sample size of 4146
records, the small number of cases in individual diseases
prevents any reliable disease-specific calibration of
ACTIVLIM.
Finally, the scale showed no DIF for language, confirming
the previous observation that ACTIVLIM is invariant regarding
language and can be consistently used in both French and Dutch
speaking communities [5].
4.4. Sensitivity to change of ACTIVLIM
The magnitude of clinical change over a relatively short time
period (i.e., 1 year) in patients with neuromuscular disorders is
dependent on the dynamics of the disease progression rate and
on the availability of efficacious therapeutic interventions. In
this respect, neuromuscular disorders can be divided in three
main categories: slowly progressive, rapidly progressive, and
those that are amenable to treatment with stabilization or
improvement. The large majority of genetic neuromuscular
disorders, in particular the large group of muscular dystrophies,
spinal muscular atrophies, and hereditary neuropathies, exhibit
slow and steady deterioration. In contrast, ALS is a rapidly
progressive disorder, which is fatal over a couple of years.
Therefore, in ALS, responsiveness is a measure of worsening,
which is more pronounced in this disease than in the muscular
dystrophies, the spinal muscular atrophies, and the hereditary
neuropathies (Fig. 5). Immune-mediated neuromuscular
disorders, including the inflammatory myopathies, myasthenia
gravis, and inflammatory neuropathies, such as CIDP, are
amenable to treatment. In these disorders, responsiveness
usually is a measure of improvement (Fig. 5). Responsiveness
can be addressed via group-level or individual-level
approaches. Group-level approaches, such as the effect size and
the standardized response mean determine to which extent a
group of patients has changed over a given period [36–38].
Individual-level approaches, such as the t-score used in this
study, are more advantageous from a clinical management
perspective since they compare the individual patient’s change
with the measurement error and determine whether each
individual patient has changed more than can be attributed to
measurement error [10,39,40]. Using the classical cut-offs of
1.96 implies that a functional progress of more than
approximately twice the measurement error is required to assert
a significant change. Here in our study, calculation of t-scores
allowed observing large and subtle differences among patients
across various diagnoses. Fig. 5 clearly indicates that
ACTIVLIM can measure different magnitudes of clinical
change in various NMD diagnoses, even though specific
questionnaires might be recommended for clinical trials that
target specific diseases.
5. Conclusions
The BNMDR ACTIVLIM dataset demonstrates the validity
of ACTIVLIM and the invariance of its item hierarchy across
gender, age, language, symptoms duration, stage of disease and
over time. Slight variations were observed across diagnostic
groups. Patients’ change in activity over one year indicated an
overall slight, though significant, decrease in activity.
ACTIVLIM allowed a longitudinal monitoring of functional
status even in a large and heterogeneous cohort of NMD
patients, providing specific quantification of change per
individual patient and per diagnosis.
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